How does Zantac lead to Breast Cancer?

In December of 2019, a 44-year-old woman in Florida filed a lawsuit against the manufacturers of Zantac (ranitidine) to seek compensation for her breast cancer. She began taking Zantac to calm her chronic heartburn nearly twenty years ago and was diagnosed with breast cancer in August 2019. The lawsuit claims that the drug’s manufacturers knew or should have known about its carcinogenic properties, but did not notify the medical community nor consumers about that risk.

There have been many similar suits against drug manufacturers since Zantac was petitioned for recall in September 2019. The recall petition was filed by a drug testing company that conducts routine assessments of medications. The company reported in June of 2019 that some of their tests showed excessive levels of N-nitrosodimethlylamine (NDMA), a known carcinogen, in ranitidine samples. Further testing has revealed that NDMA levels can increase both during storage and when present in the human body.

How is Breast Cancer Linked to Zantac?

The Florida case in 2019 presented evidence in the form of a peer-reviewed study from 2008, conducted by the Fred Hutchinson Cancer Research Center, that demonstrated a direct connection between Zantac and breast cancer. The study found that individuals who regularly took the drug increased their risk of breast cancer by 240% as opposed to those who were not on the drug.

Ranitidine has been marketed as safe by manufacturers since its introduction in 1983. Scores of individuals all over the country have been treating their heartburn, indigestion, acid reflux, and similar symptoms with the drug for years or even decades. Those who have been diagnosed with breast cancer due to regular and continued use of Zantac or similar drugs deserve compensation. Our fierce legal team at Kwartler Manus, LLC can help you with the justice you are entitled to.

What Cancers are Linked to Zantac?

In addition to breast cancer, people who have developed any of the following cancers due to consistent and prolonged use of Zantac or ranitidine drugs may be eligible for compensation:

  • Bladder cancer

  • Stomach cancer

  • Esophageal/colorectal cancer

  • Kidney/renal cancer

  • Liver cancer

  • Leukemia

  • Multiple Myeloma

  • Non-Hodgkin's Lymphoma

  • Pancreatic cancer

  • Prostate cancer

  • Small intestine cancer

How can the Experienced Lawyers at Kwartler Manus, LLC. Help You?

If you or a loved one have developed one of the cancers listed above after continuous use of Zantac (ranitidine), make sure to contact us at Kwartler Manus, LLC. Our Zantac litigation lawyers have extensive experience representing clients in similar suits. By filing a mass tort claim against the manufacturers of Zantac, you may be able to receive compensation for your pain and suffering, and protect others from future harm. Our dedicated attorneys will help you navigate this complicated process with ease and help you receive the justice you deserve. Contact our office online or by phone at (866) 840-6708 for your FREE consultation.

Categories

Put Us On Your Side

  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.